Rhythm Pharmaceuticals, Inc.

RYTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016
Assets
Cash & Equivalents $34.2M $6.5M
Accounts Receivable — —
Inventory — —
Total Current Assets $150.7M $11.2M
Property, Plant & Equipment $840.0K $930.0K
Goodwill — —
Intangible Assets (Excl. Goodwill) — —
Total Assets $151.7M $12.3M
Liabilities
Accounts Payable $2.4M $1.9M
Total Current Liabilities $6.7M $4.7M
Long-Term Debt — —
Total Liabilities $6.9M $5.0M
Stockholders' Equity
Retained Earnings $-110.3M $-76.5M
Total Stockholders' Equity $144.8M $-32.7M
← Newer Page 2 of 2 Older →